A single-center, open-label, randomized cross-over study to evaluate the pharmacokinetics and bioavailability of once-daily prolonged-release formulations of tacrolimus in de novo liver transplant recipients.

Herden, Uta; Sterneck, Martina; Buchholz, Bettina M; Achilles, Eike G; Ott, Armin; Fischer, Lutz

Herden, Uta; Sterneck, Martina; Buchholz, Bettina M; Achilles, Eike G; Ott, Armin; Fischer, Lutz.

Afiliação

Herden U; Department of Visceral Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Sterneck M; Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Buchholz BM; Department of Visceral Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Achilles EG; Department of Visceral Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Ott A; Institute of Medical Informatics, Statistics and Epidemiology, Technische Universität München, Munich, Germany.
Fischer L; Department of Visceral Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Immun Inflamm Dis ; 9(4): 1771-1780, 2021 12.

Article em En | MEDLINE | ID: mdl-34559956

Assuntos

Transplante de Fígado; Tacrolimo; Adulto; Disponibilidade Biológica; Estudos Cross-Over; Esquema de Medicação; Humanos; Imunossupressores

Palavras-chave

liver transplantation; pharmacokinetics; prolonged-release formulations; tacrolimus

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Fígado / Tacrolimo Tipo de estudo: Clinical_trials Limite: Adult / Humans Idioma: En Revista: Immun Inflamm Dis Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Alemanha

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google